These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. Jeldres C, Bensalah K, Capitanio U, Zini L, Perrotte P, Suardi N, Tostain J, Valeri A, Descotes JL, Rambeaud JJ, de La Taille A, Salomon L, Abbou C, Patard JJ, Karakiewicz PI. BJU Int; 2009 Jun 01; 103(12):1632-5. PubMed ID: 19545272 [Abstract] [Full Text] [Related]
7. A non-cancer-related survival benefit is associated with partial nephrectomy. Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI. Eur Urol; 2012 Apr 01; 61(4):725-31. PubMed ID: 22172373 [Abstract] [Full Text] [Related]
10. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding? Rouach Y, Delongchamps N, Timsit MO, Verkarre V, Fontaine E, Peyromaure M, Mejean A. BJU Int; 2010 Mar 01; 105(5):616-9. PubMed ID: 19681891 [Abstract] [Full Text] [Related]
11. Partial nephrectomy for small localized renal cell carcinoma. Uchida K, Takahashi A, Masumori N, Yanase M, Itoh N, Tsukamoto T. Hinyokika Kiyo; 2004 Jun 01; 50(6):389-95. PubMed ID: 15293735 [Abstract] [Full Text] [Related]
12. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment. Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI. Urology; 2010 Feb 01; 75(2):271-5. PubMed ID: 19962740 [Abstract] [Full Text] [Related]
15. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H. J Urol; 2004 Mar 01; 171(3):1066-70. PubMed ID: 14767272 [Abstract] [Full Text] [Related]
16. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy. Takagi T, Kondo T, Iizuka J, Kobayashi H, Hashimoto Y, Nakazawa H, Ito F, Tanabe K. Int J Urol; 2011 Jun 01; 18(6):472-6. PubMed ID: 21481013 [Abstract] [Full Text] [Related]
17. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma. Hutterer GC, Patard JJ, Colombel M, Belldegrun AS, Pfister C, Guille F, Artibani W, Montorsi F, Pantuck AJ, Karakiewicz PI. Cancer; 2007 Dec 01; 110(11):2428-33. PubMed ID: 17941033 [Abstract] [Full Text] [Related]
19. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Eur Urol; 2012 Jun 01; 61(6):1156-61. PubMed ID: 22257424 [Abstract] [Full Text] [Related]
20. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. Sun M, Bianchi M, Trinh QD, Hansen J, Abdollah F, Hanna N, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI. BJU Int; 2013 Jan 01; 111(1):67-73. PubMed ID: 22612472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]